BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

555 related articles for article (PubMed ID: 15365996)

  • 21. Nine novel pathogenic germline mutations in MLH1, MSH2, MSH6 and PMS2 in families with Lynch syndrome.
    Rahner N; Friedrichs N; Wehner M; Steinke V; Aretz S; Friedl W; Buettner R; Mangold E; Propping P; Walldorf C
    Acta Oncol; 2007; 46(6):763-9. PubMed ID: 17653898
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bethesda guidelines: relation to microsatellite instability and MLH1 promoter methylation in patients with colorectal cancer.
    Raedle J; Trojan J; Brieger A; Weber N; Schäfer D; Plotz G; Staib-Sebler E; Kriener S; Lorenz M; Zeuzem S
    Ann Intern Med; 2001 Oct; 135(8 Pt 1):566-76. PubMed ID: 11601928
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hereditary nonpolyposis colorectal cancer: frequent occurrence of large genomic deletions in MSH2 and MLH1 genes.
    Wang Y; Friedl W; Lamberti C; Jungck M; Mathiak M; Pagenstecher C; Propping P; Mangold E
    Int J Cancer; 2003 Feb; 103(5):636-41. PubMed ID: 12494471
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Eight novel germline MLH1 and MSH2 mutations in hereditary non-polyposis colorectal cancer families from Spain.
    Godino J; de La Hoya M; Diaz-Rubio E; Benito M; Caldés T
    Hum Mutat; 2001 Dec; 18(6):549. PubMed ID: 11748856
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lynch syndrome (hereditary nonpolyposis colorectal cancer) diagnostics.
    Lagerstedt Robinson K; Liu T; Vandrovcova J; Halvarsson B; Clendenning M; Frebourg T; Papadopoulos N; Kinzler KW; Vogelstein B; Peltomäki P; Kolodner RD; Nilbert M; Lindblom A
    J Natl Cancer Inst; 2007 Feb; 99(4):291-9. PubMed ID: 17312306
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of MLH1, MSH2 and MSH6 in the development of multiple colorectal cancers.
    Lawes DA; Pearson T; Sengupta S; Boulos PB
    Br J Cancer; 2005 Aug; 93(4):472-7. PubMed ID: 16106253
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Toward new strategies to select young endometrial cancer patients for mismatch repair gene mutation analysis.
    Berends MJ; Wu Y; Sijmons RH; van der Sluis T; Ek WB; Ligtenberg MJ; Arts NJ; ten Hoor KA; Kleibeuker JH; de Vries EG; Mourits MJ; Hollema H; Buys CH; Hofstra RM; van der Zee AG
    J Clin Oncol; 2003 Dec; 21(23):4364-70. PubMed ID: 14645426
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of hereditary nonpolyposis colorectal cancer-related tumors displaying low microsatellite instability with MSH6 germline mutations.
    Wu Y; Berends MJ; Mensink RG; Kempinga C; Sijmons RH; van Der Zee AG; Hollema H; Kleibeuker JH; Buys CH; Hofstra RM
    Am J Hum Genet; 1999 Nov; 65(5):1291-8. PubMed ID: 10521294
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Germline and somatic mutation analyses in the DNA mismatch repair gene MLH3: Evidence for somatic mutation in colorectal cancers.
    Lipkin SM; Wang V; Stoler DL; Anderson GR; Kirsch I; Hadley D; Lynch HT; Collins FS
    Hum Mutat; 2001 May; 17(5):389-96. PubMed ID: 11317354
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Four novel MSH2 / MLH1 gene mutations in portuguese HNPCC families.
    Isidro G; Veiga I; Matos P; Almeida S; Bizarro S; Marshall B; Baptista M; Leite J; Regateiro F; Soares J; Castedo S; Boavida MG
    Hum Mutat; 2000 Jan; 15(1):116. PubMed ID: 10612836
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of molecular tumor characteristics to prioritize mismatch repair gene testing in early-onset colorectal cancer.
    Southey MC; Jenkins MA; Mead L; Whitty J; Trivett M; Tesoriero AA; Smith LD; Jennings K; Grubb G; Royce SG; Walsh MD; Barker MA; Young JP; Jass JR; St John DJ; Macrae FA; Giles GG; Hopper JL
    J Clin Oncol; 2005 Sep; 23(27):6524-32. PubMed ID: 16116158
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BRAF-V600E is not involved in the colorectal tumorigenesis of HNPCC in patients with functional MLH1 and MSH2 genes.
    Domingo E; Niessen RC; Oliveira C; Alhopuro P; Moutinho C; Espín E; Armengol M; Sijmons RH; Kleibeuker JH; Seruca R; Aaltonen LA; Imai K; Yamamoto H; Schwartz S; Hofstra RM
    Oncogene; 2005 Jun; 24(24):3995-8. PubMed ID: 15782118
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Value of immunohistochemical detection of DNA mismatch repair proteins in predicting germline mutation in hereditary colorectal neoplasms.
    Shia J; Klimstra DS; Nafa K; Offit K; Guillem JG; Markowitz AJ; Gerald WL; Ellis NA
    Am J Surg Pathol; 2005 Jan; 29(1):96-104. PubMed ID: 15613860
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Germline mutations in MLH1, MSH2 and MSH6 in Korean hereditary non-polyposis colorectal cancer families.
    Shin YK; Heo SC; Shin JH; Hong SH; Ku JL; Yoo BC; Kim IJ; Park JG
    Hum Mutat; 2004 Oct; 24(4):351. PubMed ID: 15365995
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of MSH2 and MLH1 mutations in Italian families with hereditary nonpolyposis colorectal cancer.
    Viel A; Genuardi M; Capozzi E; Leonardi F; Bellacosa A; Paravatou-Petsotas M; Pomponi MG; Fornasarig M; Percesepe A; Roncucci L; Tamassia MG; Benatti P; Ponz de Leon M; Valenti A; Covino M; Anti M; Foletto M; Boiocchi M; Neri G
    Genes Chromosomes Cancer; 1997 Jan; 18(1):8-18. PubMed ID: 8993976
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sensitivity and specificity of clinical criteria for hereditary non-polyposis colorectal cancer associated mutations in MSH2 and MLH1.
    Syngal S; Fox EA; Eng C; Kolodner RD; Garber JE
    J Med Genet; 2000 Sep; 37(9):641-5. PubMed ID: 10978352
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical and molecular characteristics of hereditary non-polyposis colorectal cancer families in Southeast Asia.
    Lee SC; Guo JY; Lim R; Soo R; Koay E; Salto-Tellez M; Leong A; Goh BC
    Clin Genet; 2005 Aug; 68(2):137-45. PubMed ID: 15996210
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumours from MSH2 mutation carriers show loss of MSH2 expression but many tumours from MLH1 mutation carriers exhibit weak positive MLH1 staining.
    Mangold E; Pagenstecher C; Friedl W; Fischer HP; Merkelbach-Bruse S; Ohlendorf M; Friedrichs N; Aretz S; Buettner R; Propping P; Mathiak M
    J Pathol; 2005 Dec; 207(4):385-95. PubMed ID: 16216036
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MLH1 promoter germline-methylation in selected probands of Chinese hereditary non-polyposis colorectal cancer families.
    Zhou HH; Yan SY; Zhou XY; Du X; Zhang TM; Cai X; Lu YM; Cai SJ; Shi DR
    World J Gastroenterol; 2008 Dec; 14(48):7329-34. PubMed ID: 19109866
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Loss of DNA mismatch repair proteins in skin tumors from patients with Muir-Torre syndrome and MSH2 or MLH1 germline mutations: establishment of immunohistochemical analysis as a screening test.
    Mathiak M; Rütten A; Mangold E; Fischer HP; Ruzicka T; Friedl W; Propping P; Kruse R
    Am J Surg Pathol; 2002 Mar; 26(3):338-43. PubMed ID: 11859205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.